default author photo

Mark K. Louder

National Institutes of Health (NIH) - Vaccine Research Center

Bethesda, MD 20892-9806

United States

SCHOLARLY PAPERS

4

DOWNLOADS

131

TOTAL CITATIONS

2

Scholarly Papers (4)

1.

Structure of Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

Number of pages: 43 Posted: 05 Aug 2019
National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Health Laboratory Services (NHLS) - Centre for HIV and STIs, University of the Witwatersrand, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center and National Institutes of Health - Vaccine Research Center
Downloads 40 (1,183,237)
Citation 1

Abstract:

Loading...

broadly neutralizing antibody, HIV-1 envelope trimer, multidonor antibody class, PCT64, PG9, PGDM1400, PGT145, tyrosine sulfation, V1V2-apex recognition

2.

Vaccination Induces Maturation of Diverse Unmutated VRC01-Class Precursors to HIV-1 Broadly Neutralizing Antibodies in an Ig-Humanized Mouse Model

Number of pages: 156 Posted: 15 Sep 2020
National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Columbia University - Aaron Diamond AIDS Research Center, National Institutes of Health - Vaccine Research Center, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Boston Children’s Hospital - Program in Cellular and Molecular Medicine, Boston Children’s Hospital - Program in Cellular and Molecular Medicine, National Institutes of Health - Vaccine Research Center and National Institutes of Health - Vaccine Research Center
Downloads 33 (1,277,121)

Abstract:

Loading...

antibody VRC01, broadly neutralizing antibody, HIV-1 vaccine, somatic hypermutations

3.

­­­­Rapid Selection of HIV Envelopes that Bind to Neutralizing Antibody B Cell Lineage Members with Functional Improbable Mutations

Number of pages: 51 Posted: 10 Mar 2021
Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute and Duke University - Duke Human Vaccine Institute
Downloads 31 (1,304,549)

Abstract:

Loading...

4.

A Structure-Based Matrix Approach Yields Improved VRC01-Class Antibodies for HIV-1 Therapy and Prevention

Number of pages: 41 Posted: 05 Oct 2020
National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, Independent, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health - Viral Pathogenesis Section, National Institutes of Health - Vaccine Research Center and National Institutes of Health - Vaccine Research Center
Downloads 27 (1,359,097)
Citation 1

Abstract:

Loading...

antibody VRC01, broadly neutralizing antibody, HIV-1 envelope trimer, polyreactivity, prophylaxis, treatment